AbbVie Inc. Annual Costs and Expenses in USD from 2011 to 2023

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
AbbVie Inc. quarterly/annual Costs and Expenses history and growth rate from 2011 to 2023.
  • AbbVie Inc. Costs and Expenses for the quarter ending June 30, 2024 was $10.5B, a 11.9% increase year-over-year.
  • AbbVie Inc. Costs and Expenses for the twelve months ending June 30, 2024 was $42.7B, a 10.6% increase year-over-year.
  • AbbVie Inc. annual Costs and Expenses for 2023 was $41.6B, a 4.07% increase from 2022.
  • AbbVie Inc. annual Costs and Expenses for 2022 was $39.9B, a 4.35% increase from 2021.
  • AbbVie Inc. annual Costs and Expenses for 2021 was $38.3B, a 11.1% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $41.6B +$1.62B +4.07% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-20
2022 $39.9B +$1.66B +4.35% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-20
2021 $38.3B +$3.83B +11.1% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-20
2020 $34.4B +$14.2B +69.8% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-17
2019 $20.3B -$6.09B -23.1% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-18
2018 $26.4B +$7.7B +41.2% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-19
2017 $18.7B +$2.37B +14.6% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-21
2016 $16.3B +$976M +6.37% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-27
2015 $15.3B -$1.23B -7.41% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-16
2014 $16.5B +$3.42B +26.1% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-17
2013 $13.1B +$563M +4.48% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-19
2012 $12.6B -$1.26B -9.12% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-20
2011 $13.8B Jan 1, 2011 Dec 31, 2011 10-K 2014-02-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.